Artificial intelligence (AI) will be the talk of the town when over 1,500 health care stakeholders—clinicians, industry executives, researchers, investors, and policymakers—gather in Boston next week at the 2018 World Medical Innovation Forum, hosted by Partners HealthCare.

The event, to be held April 23-25 at the Westin Copley Place, will examine the increasingly transformative impact of AI—cognitive computing, machine learning, and big data—on medicine. Keynotes and panels will take a deeper dive into AI and its relationship to drug and device development, data security, costs and quality, and specific specialties such as radiology and neuropsychology. Highlights will include a “First Look” at AI solutions of the future under development by early career Harvard researchers, “Discovery Cafe” workshops hosted by senior Harvard faculty, and the introduction of the “Disruptive Dozen” in AI.

The ultimate goal of the Forum is to unleash the potential of AI to improve care while driving innovation and economic growth, according to conference chairs Anne Klibanski, MD, Chief Academic Officer, and Gregg Meyer, MD, Chief Clinical Officer, both of Partners.

“In an industry driven by data and analysis, AI is a game changer,” says Dr. Meyer. “AI methodologies—such as those relating to deep neural networks modeled after the human brain—target longstanding health care challenges. The Forum will help advance this evolution.”

To view the agenda and more information for the Forum, visit this page.

Tags: research and discovery, technology, industry interactions